Healx

Healx Overview

Founded 2014
Founded
Status Private
Employees 50
Employees
Latest Deal Type Series B
Latest Deal Amount $56M
Latest Deal Amount
Investors 16

Healx General Information

Description

Developer of a drug discovery platform intended to accelerate the discovery of new treatments for rare diseases. The company's platform uses artificial intelligence to leverage the combination of algorithms to predict and de-risk novel connections in biomedical data and move the promising ones towards the clinic, enabling clinics to develop advanced treatment methods.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Charter House
  • 66-68 Hills Road
  • Cambridge CB2 1LA
  • England, United Kingdom

Healx Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Healx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Early Stage VC (Series B) 16-Oct-2019 $56M 000.00 Completed Generating Revenue
5. Early Stage VC (Series A) 26-Jul-2018 00.00 000.00 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 05-Oct-2016 00.000 00.00 000.00 Completed Startup
3. Seed Round 15-Apr-2015 00000 00000 00.000 Completed Startup
2. Grant Completed Startup
1. Accelerator/Incubator 01-Jan-2015 Completed Startup

Healx Cap Table

To view Healx‘s complete cap table, request access »
Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A Ordinary 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A Pref 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 2,878,000 $0.000000 $0.69 $0.69 1x $0.69 13.49%
Ordinary 2,484,000 $0.000000 $0.16 $0.16 1x $0.16 11.64%

Healx Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing
Amount
Verge Genomics Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
0000000000 Venture Capital-Backed Oxford, United Kingdom 00 00000 00000000000 00000
00000000 00000000 Venture Capital-Backed Hong Kong, Hong Kong 00 000.00 00000 00000 000.00
00000 Venture Capital-Backed New York, NY 00 000.00 00000000000 000.00
00000000 Corporation Charlottesville, VA 000 0000000000 000

Healx Executive Team (21)

Name Title Board Seat Contact Info
Tim Guilliams Ph.D Co-Founder, Chief Executive Officer and Board Member
Kate Hilyard Ph.D Chief Operating Officer
Ian Roberts Chief Technology Officer
Neil Thompson Ph.D Chief Scientific Officer
Julie Charlton Clinical Director

6 Former Executives

Healx Board Members (7)

To view Healx‘s full board member team, request access »
Name Representing Role Since
David Brown Ph.D Healx Co-Founder & Chairman 000 0000
Irina Haivas MD Atomico Board Member 000 0000
Jonathan Milner Ph.D Self Board Member 000 0000
Shaun Grady Self Board Member 000 0000
Suranga Chandratillake Balderton Capital Board Member 000 0000

1 Former Board Member

Healx Investors (16)

To view Healx‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Atomico Venture Capital Minority 000 0000 000000 0
b-to-v Partners Venture Capital Minority 000 0000 000000 0
Global Brain Venture Capital Minority 000 0000 000000 0
Intel Capital Corporate Venture Capital Minority 000 0000 000000 0
R42 Group Venture Capital Minority 000 0000 000000 0

Healx Acquisitions (1)

To view Healx‘s complete investment and acquisition history, request access »
Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 19-Aug-2017 000000000000000000 Business/Productivity Software

Ready to get started?

Request a free trial